Buys
Open market- Shares
- Avg price
- Total value
Glenn Jr. MD Steele PhD - Director at PTC THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PTCT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Glenn Jr. MD Steele PhD in PTC THERAPEUTICS, INC.
Sells
Open market- Shares
- -12,000
- Avg price
- $76.35
- Total value
- -$916,200
Net
Past year- Shares
- -12,000
- Share %
- -100%
- Total value
- -$916,200
Reported holdings for Glenn Jr. MD Steele PhD in PTC THERAPEUTICS, INC.
Form 4 holding
Director
PTC THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 22,500
- Estimated value
- $1,709,100
- Report date
- 02 Jan 2026
- Price
- $75.96
- Ownership
- Direct
Form 4 holding
Director
PTC THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 3,475
- Estimated value
- $238,040
- Report date
- 02 Jan 2026
- Price
- $27.05
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Glenn Jr. MD Steele PhD in PTC THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.